Literature DB >> 3958490

The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins.

R J Fulton, J W Uhr, E S Vitetta.   

Abstract

The cytotoxicity of A chain immunotoxins containing IgG or Fab fragments specific for the surface immunoglobulin of the Daudi cell line was assessed in the presence of B chain immunotoxins (IgG or Fab) or lysosomotropic amines, or both. The concentration required for 50% inhibition of protein synthesis (IC50) in Daudi cells was 1.3 X 10(-8) M for IgG-A and 5 X 10(-8) M for Fab-A. The toxicity of both A chain immunotoxins was enhanced twofold by ammonium chloride. In the presence of A chain immunotoxins and ammonium chloride, a maximum of 99 and 90% reduction of clonal precursors was obtained with IgG and Fab-A chain immunotoxins respectively. Immunotoxins containing ricin B chain and IgG or Fab fragments specific for the antibody portion of A chain immunotoxins were used as secondary "piggyback" immunotoxins to treat cells that were pretreated with A chain immunotoxins. Both B chain immunotoxins were nontoxic at 1 X 10(-6) M. When added to target cells pretreated with specific A chain immunotoxins, the IC50 of the A chain immunotoxins was decreased up to 16-fold in the absence of ammonium chloride. In contrast to the results obtained with A chain immunotoxins alone, ammonium chloride significantly increased the toxicity of the complete piggyback system, resulting in the killing of 99.999% or five logs of target cells in the clonal assay. This decreased the IC50 of A chain immunotoxins up to 116-fold when compared with A chain immunotoxin alone. This enhanced toxicity was independent of the valency of either immunotoxin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958490

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Monoclonal antibodies. Future potential in cancer chemotherapy.

Authors:  C Kosmas; H Kalofonos; A A Epenetos
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

2.  Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA.

Authors:  Lori M Neal; Elizabeth A McCarthy; Carolyn R Morris; Nicholas J Mantis
Journal:  Vaccine       Date:  2010-11-27       Impact factor: 3.641

3.  Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB).

Authors:  Anastasiya Yermakova; Nicholas J Mantis
Journal:  Vaccine       Date:  2011-08-26       Impact factor: 3.641

4.  Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin B subunit.

Authors:  Carolyn R McGuinness; Nicholas J Mantis
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Ricin A immunotoxins of IgG and Fab of anti-CALLA monoclonal antibody: effect of water soluble long-chain SPDP on conjugate yield, immunoselectivity and cytotoxicity.

Authors:  B H Woo; J T Lee; K C Lee
Journal:  Arch Pharm Res       Date:  1994-12       Impact factor: 4.946

6.  Oral intoxication of mice with Shiga toxin type 2a (Stx2a) and protection by anti-Stx2a monoclonal antibody 11E10.

Authors:  L M Russo; A R Melton-Celsa; M A Smith; M J Smith; A D O'Brien
Journal:  Infect Immun       Date:  2013-12-30       Impact factor: 3.441

Review 7.  Immunotoxins: the role of the toxin.

Authors:  Antonella Antignani; David Fitzgerald
Journal:  Toxins (Basel)       Date:  2013-08-21       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.